остро заболяване (839 пациенти) и при пациенти, лекувани допълнително 24 дни след операция на счупена бедрена кост (656 пациенти).
The first compared the effects of Quixidar with those of enoxaparin in over 20,000 patients with unstable angina or myocardial infarction without ST segment elevation, and the second compared lo Quixidar with standard care (unfractionated heparin in eligible patients, or placebo) in over 12,000 patients with myocardial infarction with ST segment elevation.